Tiffany N. Tanaka, MD, is a board-certified hematologist specializing in the diagnosis and treatment of blood cancers and blood disorders, with an emphasis on myeloid malignancies. Dr. Tanaka is a translational researcher who focuses on the development of early phase trials that offer new cancer treatments for patients. Her research work includes the study of epigenetic and genetic biomarkers in myelodysplastic syndromes (bone marrow disorders in which the bone marrow does not produce enough healthy blood cells), with the aim of translating these into clinical therapies to improve patient care. Dr. Tanaka is a member of the American Society of Hematology, where she has presented her research work.
Dr. Tanaka completed a fellowship in hematology and oncology at UC San Diego School of Medicine, where she also completed a residency in internal medicine. She earned her medical degree from John A. Burns School of Medicine at the University of Hawai’i. She is board certified in internal medicine and hematology.
Dr. Tiffany Tanaka discusses the differences and similarities between hypoplastic MDS and aplastic anemia, with emphasis on diagnosis and treatment.
This webinar will also include an opportunity for participants to ask Dr. Tanaka questions using the text chat window. Please bring your questions for our expert!
Thank you for registering for "Aplastic Anemia and Hypoplastic MDS: A Diagnostic and Treatment Dilemma"on August 26, 2020 at 3pm EDT.
You will receive an email with a registration confirmation including the webinar link
and a call-in phone # for those participating via telephone.
If you do not receive the link, please check your Spam/Junk folders.
If you have not received a registration confirmation, please email firstname.lastname@example.org
or call (800) 747-2820 x2 no later than 30 minutes before the webinar is scheduled to begin.
If you are not able to join the webinar, an archived video will be available in 2 - 3 business days on the AAMDSIF website.